- Filed
- Feb 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Feb 9, 2026 | 2.92M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 3.95M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 3.95M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2024 | 706.55K sh |
| Shares Diluted | Q2 2026 · Dec 31, 2024 | 661.05K sh |
| Operating Cash Flow | Q2 2026 · Dec 31, 2025 | −$3.98M |
| Operating Cash Flow | Q2 2026 · Dec 31, 2024 | −$4.33M |
| Short Term Investments | Q2 2026 · Dec 31, 2025 | $42.68K |
| Short Term Investments | Q2 2026 · Jun 30, 2025 | $43.38K |
| Cash And Equivalents | Q2 2026 · Dec 31, 2025 | $6.95M |
| Cash And Equivalents | Q2 2026 · Jun 30, 2025 | $11.08M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $9.59M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $11.59M |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | $13.43M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $6.18M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $8.4M |
| Stockholders Equity | Q2 2026 · Jun 30, 2024 | $9.21M |
| Current Liabilities | Q2 2026 · Dec 31, 2025 | $1.48M |
| Current Liabilities | Q2 2026 · Jun 30, 2025 | $1.84M |
| Total Liabilities | Q2 2026 · Dec 31, 2025 | $1.6M |
| Total Liabilities | Q2 2026 · Jun 30, 2025 | $2.15M |
| Current Assets | Q2 2026 · Dec 31, 2025 | $8.79M |
| Current Assets | Q2 2026 · Jun 30, 2025 | $12.87M |
| Total Assets | Q2 2026 · Dec 31, 2025 | $11.19M |
| Total Assets | Q2 2026 · Jun 30, 2025 | $15.58M |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | −$0.51 |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | −$0.95 |
| Eps Diluted | Q2 2026 · Dec 31, 2024 | −$3.64 |
| Eps Diluted | Q2 2026 · Dec 31, 2024 | −$6.43 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | −$0.51 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | −$0.95 |
| Eps Basic | Q2 2026 · Dec 31, 2024 | −$3.64 |
| Eps Basic | Q2 2026 · Dec 31, 2024 | −$6.43 |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $1.62M |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $3.15M |
| Sga Expense restated | Q2 2026 · Dec 31, 2024 | $1.72M |
| Sga Expense restated | Q2 2026 · Dec 31, 2024 | $3.21M |
| Rd Expense | Q2 2026 · Dec 31, 2025 | $630.64K |
| Rd Expense | Q2 2026 · Dec 31, 2025 | $1.21M |
| Rd Expense restated | Q2 2026 · Dec 31, 2024 | $895.18K |
| Rd Expense restated | Q2 2026 · Dec 31, 2024 | $1.6M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$2.03M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$3.76M |
| Net Income | Q2 2026 · Sep 30, 2025 | −$1.73M |
| Net Income | Q2 2026 · Dec 31, 2024 | −$2.58M |
| Net Income | Q2 2026 · Dec 31, 2024 | −$4.25M |
| Net Income | Q2 2026 · Sep 30, 2024 | −$1.68M |
| Gross Profit | Q2 2026 · Dec 31, 2025 | $184.19K |
| Gross Profit | Q2 2026 · Dec 31, 2025 | $587.35K |
| Gross Profit | Q2 2026 · Dec 31, 2024 | $460.89K |
| Gross Profit | Q2 2026 · Dec 31, 2024 | $954.31K |
| Cost Of Revenue | Q2 2026 · Dec 31, 2025 | $635.99K |
| Cost Of Revenue | Q2 2026 · Dec 31, 2025 | $1.35M |
| Cost Of Revenue | Q2 2026 · Dec 31, 2024 | $650.81K |
| Cost Of Revenue | Q2 2026 · Dec 31, 2024 | $1.42M |